Sign in to edit your profile (add interests, mentoring, photo, etc.)

    James Sorensen, PhD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentPsychiatry
    Address1001 Potrero Ave, SFGH 20
    San Francisco CA 94143
    Phone415-206-3969

       Overview 
       Interests
      Implementation Science, Persons with Substance Use Disorders, Community-based organization, Department of public health, Education, Lobbying, HIV and AIDS, drug abuse, mental illness, Mentoring junior faculty or trainees, Interdisciplinary research collaboration, Brief implementation science training courses, Implementation & dissemination science listservs

       ORNG Applications 
       Websites
       Awarded Grants
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Woody GE, Bruce D, Korthuis PT, Chhatre S, Poole S, Hillhouse M, Jacobs P, Sorensen J, Saxon AJ, Metzger D, Ling W. HIV Risk Reduction With Buprenorphine-Naloxone or Methadone: Findings From a Randomized Trial. J Acquir Immune Defic Syndr. 2014 Jul 1; 66(3):288-93.
        View in: PubMed
      2. Flentje A, Heck NC, Sorensen JL. Characteristics of transgender individuals entering substance abuse treatment. Addict Behav. 2014 May; 39(5):969-75.
        View in: PubMed
      3. Larios SE, Masson CL, Shopshire MS, Hettema J, Jordan AE, McKnight C, Young C, Khalili M, Seewald RM, Min A, Hengl N, Sorensen JL, Des Jarlais DC, Perlman DC. Education and counseling in the methadone treatment setting improves knowledge of viral hepatitis. J Subst Abuse Treat. 2014 Apr; 46(4):528-31.
        View in: PubMed
      4. Tsai AC, Mimiaga MJ, Dilley JW, Hammer GP, Karasic DH, Charlebois ED, Sorensen JL, Safren SA, Bangsberg DR. Does effective depression treatment alone reduce secondary HIV transmission risk? Equivocal findings from a randomized controlled trial. AIDS Behav. 2013 Oct; 17(8):2765-72.
        View in: PubMed
      5. Manuel JK, Newville H, Larios SE, Sorensen JL. Confidentiality protections versus collaborative care in the treatment of substance use disorders. Addict Sci Clin Pract. 2013; 8(1):13.
        View in: PubMed
      6. Masson CL, Delucchi KL, McKnight C, Hettema J, Khalili M, Min A, Jordan AE, Pepper N, Hall J, Hengl NS, Young C, Shopshire MS, Manuel JK, Coffin L, Hammer H, Shapiro B, Seewald RM, Bodenheimer HC, Sorensen JL, Des Jarlais DC, Perlman DC. A randomized trial of a hepatitis care coordination model in methadone maintenance treatment. Am J Public Health. 2013 Oct; 103(10):e81-8.
        View in: PubMed
      7. Jordan AE, Masson CL, Mateu-Gelabert P, McKnight C, Pepper N, Bouche K, Guzman L, Kletter E, Seewald RM, Des-Jarlais DC, Sorensen JL, Perlman DC. Perceptions of drug users regarding hepatitis C screening and care: a qualitative study. Harm Reduct J. 2013; 10:10.
        View in: PubMed
      8. Newville H, Sorensen JL. The efficacy of a computerized assessment of medication adherence in active substance users. J Int Assoc Provid AIDS Care. 2013 Jul-Aug; 12(4):232-5.
        View in: PubMed
      9. Manuel JK, Lum PJ, Hengl NS, Sorensen JL. Smoking cessation interventions with female smokers living with HIV/AIDS: a randomized pilot study of motivational interviewing. AIDS Care. 2013; 25(7):820-7.
        View in: PubMed
      10. Sorensen JL, Haug NA, Larios S, Gruber VA, Tulsky J, Powelson E, Logan DP, Shapiro B. Directly administered antiretroviral therapy: pilot study of a structural intervention in methadone maintenance. J Subst Abuse Treat. 2012 Dec; 43(4):418-23.
        View in: PubMed
      11. Masson CL, Shopshire MS, Sen S, Hoffman KA, Hengl NS, Bartolome J, McCarty D, Sorensen JL, Iguchi MY. Possible barriers to enrollment in substance abuse treatment among a diverse sample of Asian Americans and Pacific Islanders: opinions of treatment clients. J Subst Abuse Treat. 2013 Mar; 44(3):309-15.
        View in: PubMed
      12. Tsai AC, Karasic DH, Hammer GP, Charlebois ED, Ragland K, Moss AR, Sorensen JL, Dilley JW, Bangsberg DR. Directly observed antidepressant medication treatment and HIV outcomes among homeless and marginally housed HIV-positive adults: a randomized controlled trial. Am J Public Health. 2013 Feb; 103(2):308-15.
        View in: PubMed
      13. Metsch LR, Feaster DJ, Gooden L, Matheson T, Mandler RN, Haynes L, Tross S, Kyle T, Gallup D, Kosinski AS, Douaihy A, Schackman BR, Das M, Lindblad R, Erickson S, Korthuis PT, Martino S, Sorensen JL, Szapocznik J, Walensky R, Branson B, Colfax GN. Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. Am J Public Health. 2012 Jun; 102(6):1160-7.
        View in: PubMed
      14. Korthuis PT, Feaster DJ, Gomez ZL, Das M, Tross S, Wiest K, Douaihy A, Mandler RN, Sorensen JL, Colfax G, McCarty D, Cohen SE, Penn PE, Lape D, Metsch LR. Injection behaviors among injection drug users in treatment: the role of hepatitis C awareness. Addict Behav. 2012 Apr; 37(4):552-5.
        View in: PubMed
      15. Larios SE, Wright S, Jernstrom A, Lebron D, Sorensen JL. Evidence-based practices, attitudes, and beliefs in substance abuse treatment programs serving American Indians and Alaska Natives: a qualitative study. J Psychoactive Drugs. 2011 Oct-Dec; 43(4):355-9.
        View in: PubMed
      16. Tross S, Campbell AN, Calsyn DA, Metsch LR, Sorensen JL, Shoptaw S, Haynes L, Woody GE, Malow RM, Brown LS, Feaster DJ, Booth RE, Mandler RN, Masson C, Holmes BW, Colfax G, Brooks AJ, Hien DA, Schackman BR, Korthuis PT, Miele GM. NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs. Am J Drug Alcohol Abuse. 2011 Sep; 37(5):283-93.
        View in: PubMed
      17. Riley ED, Moore K, Sorensen JL, Tulsky JP, Bangsberg DR, Neilands TB. Basic subsistence needs and overall health among human immunodeficiency virus-infected homeless and unstably housed women. Am J Epidemiol. 2011 Sep 1; 174(5):515-22.
        View in: PubMed
      18. Sorensen JL, Kosten T. Developing the tools of implementation science in substance use disorders treatment: applications of the consolidated framework for implementation research. Psychol Addict Behav. 2011 Jun; 25(2):262-8.
        View in: PubMed
      19. Sorensen JL. From Cat's Cradle to Beat the Reaper: getting evidence-based treatments into practice in spite of ourselves. Addict Behav. 2011 Jun; 36(6):597-600.
        View in: PubMed
      20. Masson CL, Sorensen JL, Grossman N, Sporer KA, Des Jarlais DC, Perlman DC. Organizational issues in the implementation of a hospital-based syringe exchange program. Subst Use Misuse. 2010 May; 45(6):901-15.
        View in: PubMed
      21. Song YS, Calsyn DA, Doyle SR, Dierst-Davies R, Chen T, Sorensen JL. Predictors of condom use among men enrolled in drug treatment programs. AIDS Educ Prev. 2009 Oct; 21(5):460-73.
        View in: PubMed
      22. Hettema JE, Sorensen JL, Uy M, Jain S. Motivational enhancement therapy to increase resident physician engagement in substance abuse education. Subst Abus. 2009 Jul-Sep; 30(3):244-7.
        View in: PubMed
      23. Chun J, Haug NA, Guydish JR, Sorensen JL, Delucchi K. Cigarette smoking among opioid-dependent clients in a therapeutic community. Am J Addict. 2009 Jul-Aug; 18(4):316-20.
        View in: PubMed
      24. Chen T, Masson CL, Sorensen JL, Greenberg B. Residential treatment modifications: adjunctive services to accommodate clients on methadone. Am J Drug Alcohol Abuse. 2009; 35(2):91-4.
        View in: PubMed
      25. Barnett PG, Sorensen JL, Wong W, Haug NA, Hall SM. Effect of incentives for medication adherence on health care use and costs in methadone patients with HIV. Drug Alcohol Depend. 2009 Feb 1; 100(1-2):115-21.
        View in: PubMed
      26. Sorensen JL, Andrews S, Delucchi KL, Greenberg B, Guydish J, Masson CL, Shopshire M. Methadone patients in the therapeutic community: a test of equivalency. Drug Alcohol Depend. 2009 Feb 1; 100(1-2):100-6.
        View in: PubMed
      27. Haas AL, Sorensen JL, Hall SM, Lin C, Delucchi K, Sporer K, Chen T. Cigarette smoking in opioid-using patients presenting for hospital-based medical services. Am J Addict. 2008 Jan-Feb; 17(1):65-9.
        View in: PubMed
      28. Greenberg B, Hall DH, Sorensen JL. Methadone maintenance therapy in residential therapeutic community settings: challenges and promise. J Psychoactive Drugs. 2007 Sep; 39(3):203-10.
        View in: PubMed
      29. Sorensen JL, Brown L, Calsyn D, Tross S, Booth RE, Song Y, Normand J. AIDS research in the NIDA Clinical Trials Network: emerging results. Drug Alcohol Depend. 2007 Jul 10; 89(2-3):310-3.
        View in: PubMed
      30. Riley ED, Weiser SD, Sorensen JL, Dilworth S, Cohen J, Neilands TB. Housing patterns and correlates of homelessness differ by gender among individuals using San Francisco free food programs. J Urban Health. 2007 May; 84(3):415-22.
        View in: PubMed
      31. Masson CL, Sorensen JL, Perlman DC, Shopshire MS, Delucchi KL, Chen T, Sporer K, Des Jarlais D, Hall SM. Hospital- versus community-based syringe exchange: a randomized controlled trial. AIDS Educ Prev. 2007 Apr; 19(2):97-110.
        View in: PubMed
      32. Sorensen JL, Guydish J, Zilavy P, Davis TB, Gleghorn A, Jacoby M, Sears C. Access to drug abuse treatment under Treatment on Demand policy in San Francisco. Am J Drug Alcohol Abuse. 2007; 33(2):227-36.
        View in: PubMed
      33. Barnett PG, Masson CL, Sorensen JL, Wong W, Hall S. Linking opioid-dependent hospital patients to drug treatment: Health care use and costs 6 months after randomization. Addiction. 2006 Dec; 101(12):1797-804.
        View in: PubMed
      34. Haug NA, Sorensen JL. Contingency management interventions for HIV-related behaviors. Curr HIV/AIDS Rep. 2006 Nov; 3(4):154-9.
        View in: PubMed
      35. Haug NA, Sorensen JL, Gruber VA, Lollo N, Roth G. HAART adherence strategies for methadone clients who are HIV-positive: a treatment manual for implementing contingency management and medication coaching. Behav Modif. 2006 Nov; 30(6):752-81.
        View in: PubMed
      36. Sorensen JL, Haug NA, Delucchi KL, Gruber V, Kletter E, Batki SL, Tulsky JP, Barnett P, Hall S. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend. 2007 Apr 17; 88(1):54-63.
        View in: PubMed
      37. Wasserman DA, Sorensen JL, Delucchi KL, Masson CL, Hall SM. Psychometric evaluation of the Quality of Life Interview, Brief Version, in injection drug users. Psychol Addict Behav. 2006 Sep; 20(3):316-21.
        View in: PubMed
      38. Miller WR, Sorensen JL, Selzer JA, Brigham GS. Disseminating evidence-based practices in substance abuse treatment: a review with suggestions. J Subst Abuse Treat. 2006 Jul; 31(1):25-39.
        View in: PubMed
      39. Sorensen JL. Abstinence incentives improve stimulant abusers' compliance with community-based psychosocial treatments. Evid Based Ment Health. 2006 May; 9(2):55.
        View in: PubMed
      40. Sorensen JL, Masson CL, Delucchi K, Sporer K, Barnett PG, Mitsuishi F, Lin C, Song Y, Chen T, Hall SM. Randomized trial of drug abuse treatment-linkage strategies. J Consult Clin Psychol. 2005 Dec; 73(6):1026-35.
        View in: PubMed
      41. Haug NA, Sorensen JL, Lollo ND, Gruber VA, Delucchi KL, Hall SM. Gender differences among HIV-positive methadone maintenance patients enrolled in a medication adherence trial. AIDS Care. 2005 Nov; 17(8):1022-9.
        View in: PubMed
      42. Prochaska JJ, Sorensen JL, Hall SM, Rossi JS, Redding CA, Rosen AB, Eisendrath SJ, Meisner MR. Predictors of health functioning in two high-risk groups of smokers. Drug Alcohol Depend. 2005 May 9; 78(2):169-75.
        View in: PubMed
      43. Masson CL, Sorensen JL, Phibbs CS, Okin RL. Predictors of medical service utilization among individuals with co-occurring HIV infection and substance abuse disorders. AIDS Care. 2004 Aug; 16(6):744-55.
        View in: PubMed
      44. Sorensen JL, Dilley J, London J, Okin RL, Delucchi KL, Phibbs CS. Case management for substance abusers with HIV/AIDS: a randomized clinical trial. Am J Drug Alcohol Abuse. 2003; 29(1):133-50.
        View in: PubMed
      45. Sorensen JL, Masson CL, Perlman DC. HIV/hepatitis prevention in drug abuse treatment programs: guidance from research. Sci Pract Perspect. 2002 Jul; 1(1):4-11.
        View in: PubMed
      46. Masson CL, Sorensen JL, Batki SL, Okin R, Delucchi KL, Perlman DC. Medical service use and financial charges among opioid users at a public hospital. Drug Alcohol Depend. 2002 Mar 1; 66(1):45-50.
        View in: PubMed
      47. Margolin A, Kleber HD, Avants SK, Konefal J, Gawin F, Stark E, Sorensen J, Midkiff E, Wells E, Jackson TR, Bullock M, Culliton PD, Boles S, Vaughan R. Acupuncture for the treatment of cocaine addiction: a randomized controlled trial. JAMA. 2002 Jan 2; 287(1):55-63.
        View in: PubMed
      48. Copeland AL, Sorensen JL. Differences between methamphetamine users and cocaine users in treatment. Drug Alcohol Depend. 2001 Mar 1; 62(1):91-5.
        View in: PubMed
      49. Sorensen JL, Midkiff EE. Bridging the gap between research and drug abuse treatment. J Psychoactive Drugs. 2000 Oct-Dec; 32(4):379-82.
        View in: PubMed
      50. Sorensen JL, Jacob C, Dilley J, Corey V, Yee N. Causes of death among substance users with HIV disease. AIDS. 2000 Sep 8; 14(13):2047-9.
        View in: PubMed
      51. Félix-Ortiz M, Salazar MR, González JR, Sorensen JL, Plock D. A qualitative evaluation of an assisted self-help group for drug-addicted clients in a structured outpatient treatment setting. Community Ment Health J. 2000 Aug; 36(4):339-50.
        View in: PubMed
      52. Sorensen JL, Copeland AL. Drug abuse treatment as an HIV prevention strategy: a review. Drug Alcohol Depend. 2000 Apr 1; 59(1):17-31.
        View in: PubMed
      53. Woods WJ, Guydish JR, Sorensen JL, Coutts A, Bostrom A, Acampora A. Changes in HIV-related risk behaviors following drug abuse treatment. AIDS. 1999 Oct 22; 13(15):2151-5.
        View in: PubMed
      54. Guydish J, Sorensen JL, Chan M, Werdegar D, Bostrom A, Acampora A. A randomized trial comparing day and residential drug abuse treatment: 18-month outcomes. J Consult Clin Psychol. 1999 Jun; 67(3):428-34.
        View in: PubMed
      55. Sargent R, Sorensen JL, Greenberg B, Evans G, Acampora AP. Residential detoxification for substance abusers with HIV/AIDS. Walden House Detoxification Program. J Subst Abuse Treat. 1999 Jan; 16(1):87-95.
        View in: PubMed
      56. Sorensen JL, Mascovich A, Wall TL, DePhilippis D, Batki SL, Chesney M. Medication adherence strategies for drug abusers with HIV/AIDS. AIDS Care. 1998 Jun; 10(3):297-312.
        View in: PubMed
      57. Guydish J, Werdegar D, Sorensen JL, Clark W, Acampora A. Drug abuse day treatment: a randomized clinical trial comparing day and residential treatment programs. J Consult Clin Psychol. 1998 Apr; 66(2):280-9.
        View in: PubMed
      58. Ferrando SJ, Wall TL, Batki SL, Sorensen JL. Psychiatric morbidity, illicit drug use and adherence to zidovudine (AZT) among injection drug users with HIV disease. Am J Drug Alcohol Abuse. 1996 Nov; 22(4):475-87.
        View in: PubMed
      59. Sorensen JL, Miller MS. Impact of HIV risk and infection on delivery of psychosocial treatment services in outpatient programs. J Subst Abuse Treat. 1996 Sep-Oct; 13(5):387-95; discussion 439.
        View in: PubMed
      60. Sorensen JL. Methadone treatment for opiate addicts. BMJ. 1996 Aug 3; 313(7052):245-6.
        View in: PubMed
      61. Guydish J, Werdegar D, Sorensen JL, Clark W, Acampora A. A day treatment program in a therapeutic community setting: six-month outcomes. The Walden House Day Treatment Program. J Subst Abuse Treat. 1995 Nov-Dec; 12(6):441-7.
        View in: PubMed
      62. Félix-Ortiz de la Garza M, Sorensen JL. A self-help group for drug-addicted clients. Assisted implementation in outpatient treatment. J Subst Abuse Treat. 1995 Jul-Aug; 12(4):259-68.
        View in: PubMed
      63. Muñoz RF, Ying YW, Bernal G, Pérez-Stable EJ, Sorensen JL, Hargreaves WA, Miranda J, Miller LS. Prevention of depression with primary care patients: a randomized controlled trial. Am J Community Psychol. 1995 Apr; 23(2):199-222.
        View in: PubMed
      64. Wall TL, Sorensen JL, Batki SL, Delucchi KL, London JA, Chesney MA. Adherence to zidovudine (AZT) among HIV-infected methadone patients: a pilot study of supervised therapy and dispensing compared to usual care. Drug Alcohol Depend. 1995 Mar; 37(3):261-9.
        View in: PubMed
      65. Sorensen JL, Clark WW. A field-based dissemination component in a drug abuse research center. NIDA Res Monogr. 1995; 155:186-97.
        View in: PubMed
      66. Sorensen JL, London J, Heitzmann C, Gibson DR, Morales ES, Dumontet R, Acree M. Psychoeducational group approach: HIV risk reduction in drug users. AIDS Educ Prev. 1994 Apr; 6(2):95-112.
        View in: PubMed
      67. Schwartz B, Dilley J, Sorensen JL. Case management of substance abusers with HIV disease. J Case Manag. 1994; 3(4):173-8.
        View in: PubMed
      68. McCusker J, Sorensen JL. HIV and therapeutic communities. NIDA Res Monogr. 1994; 144:232-58.
        View in: PubMed
      69. Gibson DR, Choi KH, Catania JA, Sorensen JL, Kegeles S. Psychosocial predictors of needle sharing among intravenous drug users. Int J Addict. 1993 Aug; 28(10):973-81.
        View in: PubMed
      70. Washburn AM, Fullilove RE, Fullilove MT, Keenan PA, McGee B, Morris KA, Sorensen JL, Clark WW. Acupuncture heroin detoxification: a single-blind clinical trial. J Subst Abuse Treat. 1993 Jul-Aug; 10(4):345-51.
        View in: PubMed
      71. Sorensen JL, Costantini MF, Wall TL, Gibson DR. Coupons attract high-risk untreated heroin users into detoxification. Drug Alcohol Depend. 1993 Feb; 31(3):247-52.
        View in: PubMed
      72. Pérez-Arce P, Carr KD, Sorensen JL. Cultural issues in an Outpatient Program for stimulant abusers. J Psychoactive Drugs. 1993 Jan-Mar; 25(1):35-44.
        View in: PubMed
      73. Sieber JE, Sorensen JL. Conducting social and behavioral AIDS research in drug treatment clinics. IRB. 1992 Sep-Oct; 14(5):1-5.
        View in: PubMed
      74. Sorensen JL, London J, Tusel D, Wolfe R, Washburn A. Mass media as drug users' key information source on overdoses. Am J Public Health. 1992 Sep; 82(9):1294-5.
        View in: PubMed
      75. Costantini MF, Wermuth L, Sorensen JL, Lyons JS. Family functioning as a predictor of progress in substance abuse treatment. J Subst Abuse Treat. 1992; 9(4):331-5.
        View in: PubMed
      76. Gibson DR, Sorensen JL, Wermuth L, Bernal G. Families are helped by drug treatment. Int J Addict. 1992; 27(8):961-78.
        View in: PubMed
      77. Sorensen JL, Trier M, Brummett S, Gold ML, Dumontet R. Withdrawal from methadone maintenance. Impact of a tapering network support program. J Subst Abuse Treat. 1992; 9(1):21-6.
        View in: PubMed
      78. Guydish J, Clark G, Garcia D, Downing M, Case P, Sorensen JL. Evaluating needle exchange: do distributed needles come back? Am J Public Health. 1991 May; 81(5):617-9.
        View in: PubMed
      79. Sorensen JL. Preventing HIV transmission in drug treatment programs: what works? J Addict Dis. 1991; 10(4):67-79.
        View in: PubMed
      80. Guydish JR, Abramowitz A, Woods W, Black DM, Sorensen JL. Changes in needle sharing behavior among intravenous drug users: San Francisco, 1986-88. Am J Public Health. 1990 Aug; 80(8):995-7.
        View in: PubMed
      81. Sorensen JL, London J, Wolfe R, Tusel D, Washburn A, Choi KH, Lee D. Alerting drug abusers to overdose threats: the media's role. NIDA Res Monogr. 1990; 105:469-70.
        View in: PubMed
      82. Batki SL, Manfredi LB, Sorensen JL, Jacob P, Dumontet R, Jones RT. Fluoxetine for cocaine abuse in methadone patients: preliminary findings. NIDA Res Monogr. 1990; 105:516-7.
        View in: PubMed
      83. Sorensen JL. Preventing AIDS: prospects for change in white male intravenous drug users. NIDA Res Monogr. 1990; 93:83-107.
        View in: PubMed
      84. Sorensen JL, Costantini MF, London JA. Coping with AIDS: strategies for patients and staff in drug abuse treatment programs. J Psychoactive Drugs. 1989 Oct-Dec; 21(4):435-40.
        View in: PubMed
      85. Wolfe HL, Sorensen JL. Dual diagnosis patients in the urban psychiatric emergency room. J Psychoactive Drugs. 1989 Apr-Jun; 21(2):169-75.
        View in: PubMed
      86. Sorensen JL, Guydish J, Costantini M, Batki SL. Changes in needle sharing and syringe cleaning among San Francisco drug abusers. N Engl J Med. 1989 Mar 23; 320(12):807.
        View in: PubMed
      87. Sorensen JL, Batki SL, Good P, Wilkinson K. Methadone maintenance program for AIDS-affected opiate addicts. J Subst Abuse Treat. 1989; 6(2):87-94.
        View in: PubMed
      88. Batki SL, Sorensen JL, Gibson DR, Maude-Griffin P. HIV-infected i.v. drug users in methadone treatment: outcome and psychological correlates--a preliminary report. NIDA Res Monogr. 1989; 95:405-6.
        View in: PubMed
      89. Zweben JE, Sorensen JL. Misunderstandings about methadone. J Psychoactive Drugs. 1988 Jul-Sep; 20(3):275-81.
        View in: PubMed
      90. Menicucci LD, Wermuth L, Sorensen J. Treatment providers' assessment of dual-prognosis patients: diagnosis, treatment, referral, and family involvement. Int J Addict. 1988 Jun; 23(6):617-22.
        View in: PubMed
      91. Batki SL, Sorensen JL, Faltz B, Madover S. Psychiatric aspects of treatment of i.v. drug abusers with AIDS. Hosp Community Psychiatry. 1988 Apr; 39(4):439-41.
        View in: PubMed
      92. Gold ML, Sorensen JL, McCanlies N, Trier M, Dlugosch G. Tapering from methadone maintenance: attitudes of clients and staff. J Subst Abuse Treat. 1988; 5(1):37-44.
        View in: PubMed
      93. Sorensen JL, Acampora A, Trier M, Gold M. From maintenance to abstinence in a therapeutic community: follow-up outcomes. J Psychoactive Drugs. 1987 Oct-Dec; 19(4):345-51.
        View in: PubMed
      94. Gibson D, Wermuth L, Sorensen JL, Menicucci L, Bernal G. Approval need in self-reports of addicts and family members. Int J Addict. 1987 Sep; 22(9):895-903.
        View in: PubMed
      95. Wermuth L, Brummett S, Sorensen JL. Bridges and barriers to recovery: clinical observations from an opiate recovery project. J Subst Abuse Treat. 1987; 4(3-4):189-96.
        View in: PubMed
      96. Sorensen JL, Gibson D, Bernal G, Deitch D. Methadone applicant dropouts: impact of requiring involvement of friends or family in treatment. Int J Addict. 1985 Aug; 20(8):1273-80.
        View in: PubMed
      97. Sorensen JL, Hargreaves WA, Friedlander S. Choosing a Global Assessment Scale to describe the functioning of children. Arch Gen Psychiatry. 1984 Dec; 41(12):1186.
        View in: PubMed
      98. Sorensen JL, Acampora A, Iscoff D. From maintenance to abstinence in a therapeutic community: clinical treatment methods. J Psychoactive Drugs. 1984 Jul-Sep; 16(3):229-39.
        View in: PubMed
      99. Sorensen JL, Acampora AP, Deitch DA. From maintenance to abstinence in a therapeutic community: preliminary results. J Psychoactive Drugs. 1984 Jan-Mar; 16(1):73-7.
        View in: PubMed
      100. Sorensen JL, Deitch DA, Acampora A. Treatment collaboration of methadone maintenance programs and therapeutic communities. Am J Drug Alcohol Abuse. 1984; 10(3):347-59.
        View in: PubMed
      101. Hargreaves WA, Tyler J, Weinberg JA, Sorensen JL, Benowitz N. (--)-alpha-Acetylmethadol effects on alcohol and diazepam use, sexual function and cardiac function. Drug Alcohol Depend. 1983 Dec; 12(4):323-32.
        View in: PubMed
      102. Sorensen JL, Hargreaves WA, Weinberg JA. Withdrawal from heroin in three or six weeks: comparison of LAAM versus methadone. NIDA Res Monogr. 1982 Apr; 41:230-1.
        View in: PubMed
      103. Sorensen JL, Hargreaves WA, Weinberg JA. Heroin addict responses to six weeks of detoxification with LAAM. Drug Alcohol Depend. 1982 Feb; 9(1):79-87.
        View in: PubMed
      104. Sorensen JL, Hargreaves WA, Weinberg JA. Withdrawal from heroin in three or six weeks. Comparison of methadyl acetate and methadone. Arch Gen Psychiatry. 1982 Feb; 39(2):167-71.
        View in: PubMed
      105. Sorensen JL, Hargreaves WA, Friedlander S. Child global rating scales: selecting a measure of client functioning in a large mental health system. Eval Program Plann. 1982; 5(4):337-47.
        View in: PubMed
      106. Sorensen JL, Kantor L, Margolis RB, Galano J. The extent, nature, and utility of evaluating consumer satisfaction in community mental health centers. Am J Community Psychol. 1979 Jun; 7(3):329-37.
        View in: PubMed
      107. Sorensen JL. Outcome evaluation of a referral system for juvenile offenders. Am J Community Psychol. 1978 Aug; 6(4):381-8.
        View in: PubMed
      Back to TOP